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Mammalian  cells  store  genetic  information  in  two 
cellular  compartments:  the  nucleus  and  the  mito­
chondria. Mitochondrial DNA is packaged, handled and 
inherited independently of the nuclear genome, and far 
less is known about the regulation of mitochondrial gene 
expression compared with that of nuclear genes. As the 
singular site of the generation of adenosine triphosphate 
(ATP)  by  oxidative  phosphorylation  in  the  eukaryotic 
cell,  the  regulation  of  mitochondrial  functions  are 
complex  and  must  be  tightly  regulated  to  respond  to 
cellular  metabolic  requirements  [1,2].  The  majority  of 
proteins present in mitochondria are encoded and trans­
cribed in the nucleus [3], but the mitochondrial genome 
encodes a handful of proteins crucial for the generation 
of  ATP  (Figure  1).  These  proteins  are  transcribed  and 
translated in the mitochondrial matrix and do not enter 
the cytoplasm [4,5]. Because both the nuclear and the 
mitochondrial genomes contribute to the mitochondrial 
proteome, their regulatory coordination is critical to cell 
survival and energy homeostasis [6]. This coordination is 
complicated by the distinct packaging and environment 
of the two genomes (Box 1).
Regulation of mitochondrial gene expression is poorly 
characterized  relative  to  that  of  the  nucleus.  Nuclear­
encoded transcriptional regulatory proteins called trans­
cription factors can potentially influence mitochondrial 
gene expression in two quite different ways ­ indirectly or 
directly. They can act as ‘indirect regulators’ by regulating 
the  transcription  of  nuclear­encoded  genes  relevant  to 
mito  chondrial  function  and  biogenesis.  Indirect  regu­
lators  include  the  nuclear  respiratory  factors  1  and  2 
(NRF­1, NRF­2), which regulate the expression of nuclear­
encoded  components  of  the  mitochondrial  respira  tory 
chain and the basal transcription machinery [7] (Figure 2). 
Alternatively, they can be imported into the mitochon­
drion  and  alter  transcription  from  the  mitochondrial 
genome  as  ‘direct  regulators’  of  mitochondrial  gene 
expres  sion (Figure 2). Whereas the majority of mito  chon­
drial transcriptional regulators act indirectly, a handful of 
nuclear  transcription  factors  appear  to  act  in  both 
environ  ments  and  have  been  partly  characterized  as 
direct regulators of mitochondrial gene expression.
Nuclear  transcription  factors  were  first  identified  as 
acting  in  mitochondria  15  years  ago,  and  these  early 
reports  included  the  glucocorticoid  receptor  [8],  the 
tumor suppressor p53 [9] and the mitochondrial receptor 
for the thyroid hormone tri­iodothyronine (T3), named 
p43 [10]. The crucial demonstration that mitochondrial 
gene  expression  can  be  regulated  without  a  change  in 
nuclear gene expression came a few years later, using bio­
chemically isolated mitochondria. The observation that 
thyroid  hormone  treatment  of  isolated  mitochondria 
altered mitochondrial gene expression despite the absence 
of a nucleus indicated that mitochondrial gene expression 
was not only regulated indirectly, via the nucleus. It also 
suggested  that  a  T3  receptor  might  be  acting  directly 
within the mitochondria as a regulator of transcription 
from the mitochondrial genome.
Mitochondrial dysfunction is known to contribute to 
aging [11] and to diseases, including cancer [12], diabetes 
[13]  and  obesity  [14],  but  despite  the  boom  in  trans­
cription factor biology facilitated by emerging technolo­
gies such as chromatin immunoprecipitation (ChIP), the 
mitochondrial  role  of  nuclear  transcription  factors  is 
understudied. This is in part due to technical challenges 
of disambiguating indirect regulation from direct regu­
lation when both are mediated by the same transcription 
factor or signaling pathway. In this review we discuss the 
methods  used  to  dissect  the  functions  of  nuclear  and 
mitochondrial  transcription  factors,  and  discuss  five 
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© 2010 BioMed Central Ltdwell­characterized  examples  of  nuclear­encoded  gene 
regulatory proteins that act in mitochondria.
Techniques for distinguishing nuclear and 
mitochondrial roles of mammalian transcription 
factors
The techniques summarized in Table 1 have been applied 
to the study of nuclear transcription factors in mito  chon­
dria with the aim of addressing three major questions. Is 
the  factor  localized  to  mitochondria?  Is  the  putative 
mitochondrial role independent from the nuclear role? 
Does the factor bind to the mitochondrial DNA and/or 
regulate mitochondrial gene expression? Up to now there 
has  been  an  emphasis  on  electro­mobility  shift  assays 
(EMSAs) and nuclear reporter constructs to validate the 
binding of a transcription factor to specific mitochondrial 
DNA  sequences.  But  given  the  distinctly  different 
molecular  environments  involved,  claims  that  nuclear 
trans  cription  factors  directly  bind  the  mitochondrial 
genome in vivo have been controversial. A more physio­
logical  system  is  to  use  isolated  mitochondria  in  in 
organello  transcription  assays  [15].  With  the  increased 
availability  of  genomics  techniques  and  ChIP­grade 
antibodies,  the  direct  in  vivo  identification  of  protein­
DNA  contacts  in  mitochondria  could  become  routine 
[16].  In  nuclear  transcription  studies,  ChIP  is  a  gold 
standard  for  detecting  in  vivo  interactions  between  a 
factor of interest and the genome, and these methods can 
be readily adapted to mitochondrial investigations. ChIP 
Figure 1. Organization of the mammalian mitochondrial 
genome. Thirteen protein-coding genes (yellow), twenty-two 
tRNA genes (red) and two rRNA genes (orange) are encoded on a 
single circular nucleic acid and transcribed from three promoters 
(blue): LSP, HSP1 and HSP2, which are situated in a single region 
called the D-loop, which contains regulatory sequences that control 
transcription from all three promoters, including motifs for DNA-
binding proteins such as Tfam. The inner circle of genes is encoded 
on the (-) strand and transcribed from the LSP promoter. The outer 
circle of genes is encoded on the (+) strand and transcribed from the 
HSP1 and HSP2 promoters. Transcription from HSP2 is terminated 
distal to the 16S rRNA gene. The resulting three polycistronic 
transcripts are processed by enzymatic excision of the tRNAs (red). 
ATP6, ATP8, subunits of ATP synthase F0; Cox1, Cox2, Cox3, subunits of 
cytochrome oxidase; CytB, cytochrome B, Nd1, Nd2, Nd3, Nd4, Nd4L, 
Nd5, Nd6, subunits of NADH dehydrogenase.
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Box 1 Mitochondria and mitochondrial gene regulation
The mitochondrion is the single cellular site of ATP generation 
via aerobic respiration, and metabolites such as dietary lipids 
and pyruvate, the metabolic product of glycolysis, are actively 
transported into mitochondria [79]. As the tricarboxylic acid cycle 
progresses within the mitochondrial matrix, a series of electron-
transfer reactions, known collectively as the electron-transport 
chain, proceeds between large multiprotein complexes and 
small electron carriers within the inner membrane and matrix [5]. 
The resulting electrochemical gradient generates bioavailable 
ATP via a rotating inner-membrane ATPase, which couples 
proton flow down a proton gradient to the catalysis of the 
phosphorylation of ADP to ATP using inorganic phosphate [80].
The mitochondrion is derived from a symbiotic 
α-proteobacterium [81], and so the mitochondrial genome 
is packaged and structured differently from the nuclear 
genome [82]. The sequence of the mitochondrial genome 
and the translation machinery are also more similar to that 
of a bacterium than to eukaryotic systems [83], and the 
mitochondrial transcription machinery is reminiscent of that 
used by bacteriophages [84]. In contrast to the chromatin-based 
packaging of the nuclear genome, the mitochondrial genome 
is packaged into non-chromatin nucleoids involving proteins 
specific to mitochondria, such as Tfam [4,85]. Although the 
mammalian mitochondrial DNA is small, at around 16.5 kb, it 
nevertheless encodes 13 protein-coding genes, 22 tRNA genes 
and 2 rRNA genes, as shown in Figure 1 [86]. Unlike nuclear 
genes, each of which often has multiple dedicated promoters, 
all mitochondrial genes are expressed together from only 
three promoters encoded in the regulatory D-loop region [87], 
which are recognized by the mitochondrial basal transcriptional 
machinery: the mitochondrial RNA polymerase (Polrmt), and 
the mitochondrial transcription factors Tfam and Tfb2m [4,88]. 
The resulting three polycistronic transcripts do not undergo 
splicing, and are processed by an RNase that excises tRNAs to 
release the mRNA and rRNA [9,89] before mRNA translation in the 
mitochondrial matrix.
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criptional regulators rather than on tagged overexpressed 
protein constructs, and can thus indicate the presence or 
absence of mitochondrial binding in vivo. The successful 
use of techniques such as ChIP, immunoelectron micro­
scopy, EMSA, co­immunoprecipitation, and subcellular 
fractionation  followed  by  immunoblotting  is  highly 
dependent on antibody specificity. Indeed, one antibody 
used  to  detect  the  phosphorylated  form  of  the  cyclic­
AMP  response  element  binding  protein  (CREB)  in 
immunostaining  and  cellular  localization  studies  was 
recently  shown  to  cross­react  with  pyruvate  dehydro­
genase, an abundant enzyme in mitochondria [17]. This 
case highlights the need for antibody validation.
Proteomics studies over the past decade have attemp­
ted to characterize the complete mammalian mitochon­
drial proteome [1,2,18]. While these studies have revealed 
the responsiveness of mitochondria to cell signaling and 
the tissue specificity of mitochondrial function, they have 
rarely  identified  direct  mitochondrial  transcriptional 
regulators. DNA­damage repair proteins and other DNA­
binding  proteins  seem  difficult  to  detect  using  mass 
spectrometry because of their low relative abundance [1]. 
Subtractive  proteomics  ­  the  differential  detection  of 
proteins  in  a  mitochondrial  sample  relative  to  a 
cytoplasmic/nuclear sample ­ can increase the sensitivity 
of a mass spectrometric analysis, but at the cost of not 
detecting proteins with a role in multiple organelles [2]. 
Both  the  proteomics  and  genomics  tools  used  in 
mitochondrial  studies  are  improving  rapidly,  and  as  a 
result the number of nuclear transcription factors shown 
to play a direct role in mitochondrial regulation is likely 
to increase.
Nuclear transcription factors as direct regulators of 
mitochondrial gene expression
The  nuclear  transcription  factors  best  characterized  as 
direct  regulators  of  mitochondrial  gene  expression  in 
mammals  are  the  T3  receptor  p43,  CREB,  the  tumor 
suppressor  p53,  signal  transducer  and  activator  of 
transcription 3 (Stat3) and the estrogen receptor. p43 and 
CREB  are  transcription  factors  that  can  bind  mito­
chondrial DNA to regulate gene expression. p53, Stat3, 
and, potentially, the estrogen receptor are thought to act 
as co­regulators, affecting mitochondrial gene expression 
through protein­protein interactions.
The T3 receptor
The thyroid hormone T3 is a primary regulator of mam­
malian mitochondrial biogenesis [19] and can influence 
mitochondrial function both indirectly and directly. In its 
indirect role, it binds to members of the nuclear receptor 
superfamily of transcription factors known as T3 receptor 
α and β (T3Rα and T3Rβ) to regulate nuclear gene trans­
cription [20] (Figure 3). Nuclear transcriptional targets of 
these receptors include genes that stimulate mitochon­
drial biogenesis, such as those encoding the transcription 
factor  nuclear  respiratory  factor  1  (NRF­1)  and  the 
cofactor  PGC­1α  [21,22]  as  well  as  the  mitochondrial 
basal transcription factor Tfam [23,24].
T3  also  regulates  mitochondrial  function  directly  via 
two  pathways:  the  regulation  of  nucleotide  transport 
across  the  inner  membrane  via  a  T3­binding  adenine 
nucleotide  transporter  (AdNT)  [25,26];  and  control  of 
mitochondrial  transcription  via  the  mitochondrially 
localized  T3Rα1  isoform  known  as  p43  (Figure  3; 
reviewed  in  [27,28],  see  also  [10]).  Most  proteins  are 
imported  into  mitochondria  in  an  ATP­dependent 
manner via the protein translocator channel TOM, which 
recognizes an amino­terminal mitochondrial localization 
signal that is then cleaved during import. p43, however, is 
imported  into  rat  liver  mitochondria  via  a  different 
pathway, previously shown for the yeast mitochondrial 
transcription factor MTF1 [15], which is independent of 
both TOM and mitochondrial ATP levels, and does not 
result in cleavage of the imported protein.
One  potential  mechanism  by  which  transcription 
factors  could  be  accurately  sorted  among  different 
cellular compartments is revealed when considering the 
T3  receptors.  It  was  noticed  that  a  protein  construct 
mimicking  a  T3Rβ  isoform  with  a  truncated  amino 
terminus  (which  is  the  form  present  in  most  non­
mammalian  vertebrates)  is  specifically  imported  into 
isolated  rat  mitochondria,  suggesting  a  role  for  the 
Figure 2. The mammalian mitochondrion. The mitochondrion 
is the site of ATP generation via the tricarboxylic acid (TCA) cycle 
and the electron-transport chain, and the mitochondrial genome 
(mtDNA) exists in multiple copies per mitochondrion. The majority of 
mitochondrially localized proteins, including the basal transcription 
machinery (Tfam, Tfb2m and Polmrt), are encoded in the nucleus, 
where their expression is controlled by nuclear transcription factors 
(such as the estrogen receptor (ER) and NRF-1). Their mRNAs are 
then translated in the cytoplasm and the proteins imported into 
mitochondria.
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p43 is itself a truncated form of the full­length nuclear 
transcription  factor  T3Rα  and  is  translated  from  an 
alternative  start  site  in  the  T3Rα  mRNA  [15,29].  The 
expression of p43 is, however, regulated independently 
from the full­length T3Rα and it shows a distinct tissue­
specific pattern of expression [29].
T3 receptors associate with nuclear DNA in a sequence­
specific manner via T3­response elements (T3REs), DNA 
motifs first recognized in the promoters of T3­responsive 
genes. Multiple T3REs have been identified in the mouse 
mitochondrial  genome  that  confer  responsiveness  to 
thyroid  hormone  in  nuclear  reporter  assays,  and  p43 
binds to these sequences in vitro in EMSAs. These tech­
niques do not, however, address the question of whether 
p43 binds mitochondrial DNA in vivo under physiological 
conditions.  This  was  partly  addressed  in  a  series  of 
studies  utilizing  induced­hypothyroid  rats,  in  which 
physiological  T3  levels  were  found  to  regulate  mito­
chondrial gene expression directly in vivo. Mitochondria 
isolated from the livers of these rats showed that changes 
in  physiological  thyroid  hormone  levels  altered  the 
relative levels of mitochondrial mRNA and rRNA, which 
correlated  with  altered  protein  occupation  of  the 
mitochondrial  D­loop  as  determined  by  DNA  foot­
printing  [30].  The  independence  of  this  direct 
Table 1. Techniques used to investigate nuclear transcription factors in mitochondria
Method  Summary  References
Experimental question: Is the factor localized to mitochondria?
Subcellular fractionation  Centrifugation separates the mitochondrial, nuclear and cytoplasmic fractions of a   CREB [38], ER [4,18,90] 
  cell sample. Immunoblotting for known mitochondrial, nuclear and cytoplasmic proteins  
  assesses the efficiency of the fractionation process. Further immunoblotting establishes  
  presence of factor of interest in mitochondrial fraction.
Immunoelectron microscopy  Labeling of intact cell preparations with specific antibodies conjugated to a heavy   CREB [38] 
  metal, such as gold. Transmission electron microscopy is used to visually analyze  
  co-localization of the gold with the distinctly identifiable mitochondria.
Mitochondrial import analysis  Observing the uptake of an in vitro translated radiolabeled protein of interest into   CREB [39], p43 [15]
  isolated intact mitochondria, in the absence of a nucleus or any external stimulation.
Co-immunoprecipitation  Inference of mitochondrial localization for a protein by characterization of a physical   p53 [56] 
  interaction with a known mitochondrial protein. 
Experimental question: Is the putative mitochondrial role independent from the factor’s nuclear role?
In organello systems  Isolation of intact mitochondria and observation of their response to stimulation of the   p43 [30]
  factor of interest (for example, by addition of a hormone ligand).
Mitochondrion-specific   Overexpression of a mitochondrion-specific isoform of a transcription factor or fusion of  CREB [40], p43 [91] 
overexpression  a transcription factor with a constitutive mitochondrial localization signal. Altered  
  transcription from the mitochondrial genome in the absence of altered nuclear target  
  expression suggests direct regulation of mitochondrial gene expression by that factor.
Experimental question: Does the factor bind to the mitochondrial DNA and/or regulate mitochondrial gene expression?
Chromatin   Assay of specific protein-DNA interactions by the crosslinking of proteins to DNA  CREB [40], p53 [54] 
immunoprecipitation (ChIP)  followed by antibody-based enrichment of a protein of interest. The DNA bound to that  
  factor can then be assayed site-specifically by quantitative PCR, or on a genome-wide  
  scale by microarray analysis or high-throughput sequencing. Used to detect direct  
  binding of a factor to mtDNA.
DNA footprinting  Assay of protein-DNA interactions nonspecifically by crosslinking protein to DNA   p43 [30,32], CREB [40] 
  followed by DNase digestion or dimethylsulfate treatment. Protein-bound DNA  
  sequences are protected from digestion or methylation. Regions of mtDNA are then  
  assayed for a change in protection pattern following stimulation of a specific protein  
  or pathway.
Electro-mobility shift assay   Detects the capacity of a pool of proteins (for example, a mitochondrial extract) to bind  p43 [15], CREB [38], ERβ [67] 
(EMSA)  to a short sequence of synthesized DNA, causing it to run slower (and thus ‘shift’ higher)  
  than non-complexed DNA on a non-denaturing polyacrylamide gel. The addition of  
  antibodies against the protein of interest gives specificity. Antibodies can be applied  
  before mixing extract with DNA, resulting in loss of ‘shift’, or afterwards resulting in  
  increased ‘shift’.
Transcriptional reporter assays  Use of nuclear transcription constructs containing a putative regulatory sequence   p43 [15], p53 [56] 
  derived from mtDNA, upstream of a nuclear promoter and a reporter gene such as  
  luciferase. Changed expression of the construct following stimulation of the transcription  
  factor of interest shows that these mitochondrial sequences can act as regulatory  
  elements when placed in a nuclear context.
mtDNA, mitochondrial DNA.
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indirect  role  was  shown  when  isolated  mitochondria 
from  hypo  thyroid  rats  were  treated  with  T3  and  the 
mitochondrial  mRNA:rRNA  ratio  and  the  pattern  of 
DNA footprinting returned to that of normal rats [30]. 
This  indicated  that  T3  regulates  mitochondria  directly 
and  suggested  that  this  pathway  may  involve  a 
mitochondrial  T3  receptor  with  similar  binding 
preferences to the nuclear form.
The role of p43 in T3­mediated regulation of mitochon­
drial  transcription  was  confirmed  using  the  same  in 
organello system from induced­hypothyroid rats to show 
that  the  addition  of  p43  (translated  in  vitro  to  avoid 
possible contamination by cellular components) stimu­
lated mitochondrial gene transcription in the presence of 
T3 [15], whereas T3 treatment in the absence of p43 did 
not  stimulate  mitochondrial  gene  expression  [15].  In 
validation of the mitochondrial role of p43 in vivo, mice 
overexpressing p43 under the control of a muscle­specific 
promoter  exhibited  increased  mitochondrial  gene 
expres  sion and mitochondrial biogenesis in muscle, and 
had increased oxidative metabolism, with body tempera­
ture 0.8°C higher than control mice [31].
The direct regulation of mitochondrial transcription by 
T3  is  complex  and  highly  tissue  specific.  In  organello 
studies  that  demonstrate  the  responsiveness  of  liver 
mitochondrial transcription to T3 also demonstrate that 
mitochondria  from  the  heart  are  not  regulated  in  this 
manner. Rather, T3 regulation of mitochondria from the 
hearts of the induced­hypothyroid rats is indirect ­ via 
the  nucleus  ­  and  primarily  at  the  level  of  regulating 
mitochondrial DNA copy number [32]. This complexity 
is likely to be shared by other transcription factors with a 
direct  mitochondrial  activity,  and  it  may  explain  why 
early work did not detect direct binding of a protein to 
the  proposed  mitochondrial  T3REs  [30]  despite  the 
requirement  of  a  DNA­binding  domain  in  p43  for  the 
observed mitochondrial function [15]. Regardless of this 
outstanding debate over the location of p43 binding to 
mitochondrial DNA, evidence is overwhelming that p43 
is localized to the mitochondria in rat liver, where it binds 
to  the  mitochondrial  genome  and  regulates  mitochon­
drial transcription. A great deal remains to be studied 
regarding p43 in mitochondria ­ for example, it is not 
clear whether this regulatory pathway is conserved with­
in  mammals,  or  in  which  other  tissues  it  is  utilized. 
Nevertheless,  the  studies  on  thyroid  hormone  and 
thyroid hormone receptor were the first direct illustration 
that mitochondrial gene expression is regulated indepen­
dently  from  nuclear  gene  expression  and  introduced  a 
key model system for the study of nuclear transcription 
factors in mitochondria.
Cyclic-AMP response element binding protein (CREB)
The  transcription  factor  CREB  regulates  nuclear  gene 
expression  in  response  to  a  diverse  range  of  stimuli 
[33,34]. CREB is activated by phosphorylation, either by 
the cyclic­AMP responsive protein kinase A (PKA) or by 
other kinases, including mitogen­activated protein kinases 
(MAPKs)  and  Ca2+/calmodulin­dependent  kinases 
(CaMKs) [35]. A self­contained CREB pathway exists in 
mitochondria, which involves PKA [36], cyclic AMP [37] 
and  CREB  [38].  On  stimulation,  this  pathway  induces 
binding of phosphorylated CREB to cyclic­AMP response 
elements (CREs) in the mitochondrial DNA D­loop and 
regulation  of  mitochondrial  gene  expression  [39,40] 
(Figure 1).
CREB was first localized to rat brain mitochondria by 
subcellular  fractionation  followed  by  immunoelectron 
micro  scopy  [38].  Despite  not  having  a  classical  mito­
chondrial  localization  signal,  the  transport  of  labeled 
CREB into isolated rat liver mitochondria depends on the 
mitochondrial translocator TOM, the import route for 
most proteins into mitochondria [39]. The mitochondrial 
pool  of  CREB  can  co­immunoprecipitate  with  the 
chaper  one protein mtHSP70 [40], suggesting a mecha­
nism of targeting to the mitochondria that is dependent 
on  chaperone  proteins  rather  than  on  a  mitochondrial 
localization signal, as has been shown for p53 [41]. Once 
Figure 3. Regulation of mitochondrial function by a thyroid 
hormone. Indirect regulation: binding the thyroid hormone tri-
iodothyronine (T3) to the T3 receptor (T3R) leads to upregulation of 
transcriptional regulators of mitochondrial biogenesis, such as NRF-1 
and PGC-1α. NRF-1 and PGC-1α then can upregulate transcription of 
the nuclear-encoded mitochondrial basal transcription machinery 
(Tfam, Polrmt), which stimulates mitochondrial DNA (mtDNA) 
replication and mitochondrial biogenesis. Direct regulation: thyroid 
hormone binds directly to two mitochondrial proteins, the inner 
mitochondrial membrane adenine nucleotide transporter (AdNT) 
and a truncated version of T3R located in the mitochondrial matrix. T3 
regulates expression from the mitochondrial genome via T3R, which 
may bind directly to the mitochondrial DNA.
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in response to the same stimuli as in the nucleus, and in 
vitro  can  bind  oligonucleotides  bearing  the  consensus 
CRE sequence [38]. Binding of CREB to the mitochon­
drial D­loop (Figure 1) has been detected in vivo using 
ChIP [36] and DNase footprinting, and is dependent on 
mitochondrial  PKA  activity  [40,41].  Unlike  p43,  mito­
chondrial  localization  of  CREB  has  been  identified  in 
multiple mammalian species and tissues [36,38,39].
An overexpression construct that selectively increases 
levels of CREB in mitochondria was used to distinguish 
CREB  nuclear  and  mitochondrial  regulatory  roles  in 
primary  cultured  neurons  from  rat  brain  [40].  These 
increases in mitochondrial CREB perturbed mitochon­
drial  gene  expression  without  altering  the  expression 
levels of CREB’s nuclear target, c­fos [40]. The mRNAs of 
mitochondrially encoded NADH dehydrogenase subunits 
2, 4 and 5 (Figure 1) were specifically upregulated; con­
versely, these mRNAs were downregulated on treatment 
with  a  dominant­negative  form  of  CREB  in  the 
mitochondria [40].
Tumor suppressor protein p53
The  tumor  suppressor  protein  p53  is  a  well­known 
example of a nuclear transcription factor with a role in 
mitochondria [42]. First identified by its transcriptional 
regulatory function [43], p53 also has non­transcriptional 
functions,  and  has  been  implicated  in  apoptosis  [44], 
senescence  [45],  autophagy  [46],  DNA­damage  repair 
and cell­cycle arrest [47].
In mitochondria, p53 directly regulates apoptosis via 
protein­protein interactions at the outer membrane, and 
this  function  has  been  reviewed  thoroughly  elsewhere 
[48,49].  However,  there  is  considerable  evidence  for  a 
second  mitochondrial  role  for  p53,  in  mitochondrial 
DNA maintenance and in mitochondrial DNA­damage 
repair.  Co­immunoprecipitation  of  p53  with  the 
mitochondrion­specific transcription and mitochondrial 
DNA  packaging  factor  Tfam  suggests  that  p53  may 
regulate DNA­damage repair in mitochondria [50], as it 
does  in  the  nucleus  [51,52].  In  KB  human  epidermoid 
cancer cells and in HCT116 adenocarcinoma cells, p53 
physically  interacts  with  Tfam,  with  the  effect  of 
enhancing  the  binding  of  Tfam  to  cisplatin­damaged 
DNA at the expense of oxidized DNA, in a reversal of 
Tfam’s normal binding pattern [50].
p53 also seems to play a role in mitochondrial base­
excision repair. In a nucleus­free in vitro system derived 
from the mitochondria of mouse liver, p53 can stimulate 
the  gap­filling  function  of  the  mitochondrial  DNA 
polymerase mtPOLγ [53]. A physical interaction between 
p53 and mtPOLγ in vivo has been detected in HCT116 
cells [54], where p53 enhances the replication function of 
mtPOLγ and interacts with the mitochondrial genome. 
The  observed  binding  of  p53  to  the  mitochondrial 
genome was stimulated by, but not dependent on, DNA 
damage,  suggesting  that  the  role  of  p53  at  the  mito­
chondrial DNA may not be confined to the DNA­damage 
response. Furthermore, in studies comparing mitochon­
dria from p53­deficient cell lines with those from isogenic 
p53­positive lines, p53 appears to provide an endogenous 
proofreading function for mtPOLγ during mitochondrial 
DNA replication [55].
Despite clear localization of p53 to the mitochondrial 
matrix  and  a  number  of  direct  associations  with 
mitochondrial  DNA,  evidence  that  p53  can  bind 
sequence­specifically to regulate expression of mitochon­
drially encoded genes remains elusive. Sequences from 
the  mouse  mitochondrial  genome  that  resemble  the 
nuclear binding motif of p53 confer p53 responsiveness 
in nuclear reporter assays [56], but there is no evidence 
that p53 regulates transcription from the mitochondrial 
genome.  Regardless  of  whether  p53  directly  regulates 
mitochondrial  transcription,  it  plays  important 
mitochondrial  roles  in  apoptosis,  DNA  integrity  and 
response to stress.
Signal transducer and activator of transcription 3 (Stat3)
Stat3 was first detected in mitochondria as a result of its 
functional  association  with  GRIM­19,  a  subunit  of  the 
respiratory electron­transport chain NADH dehydro  ge­
nase  (Complex  I),  which  functions  in  the  transfer  of 
electrons from NADH to the respiratory chain [57,58]. In 
the nucleus, Stat3 mediates the transcriptional response 
to  growth  factors  such  as  interleukin­6  and  epithelial 
growth factor [59]. Differences between Stat3 function in 
the mitochondria and nucleus are exemplified by the fact 
that the mitochondrial pool of Stat3 mediates oncogenic 
transformation  by  the  small  GTPase  H­Ras,  a  process 
that is mechanistically distinct from how nuclear Stat3 
supports oncogenic transformation by the viral oncogene 
v­Src [60]. Both Stat3­knockdown cell lines and Stat3­
knockout mice show disrupted electron­transport chain 
function [61], which suggests that Stat3 directly regulates 
mitochondrial  function  via  its  effects  on  the  electron­
transport chain. Engineered Stat3 mutant proteins have 
shown that the nuclear role and the mitochondrial role 
can be functionally isolated [61].
The estrogen receptor
The  estrogen  receptor  was  first  found  to  localize  to 
mitochondria  of  rabbit  uterus  and  ovary  in  2001  [62]. 
This  receptor  regulates  gene  expression  by  binding  to 
estrogen­response  elements  (EREs)  in  gene  promoters 
following the binding of the steroid hormone estrogen to 
the receptor [63]. Nuclear targets include NRF-1, which, 
as  noted  earlier,  encodes  a  transcription  factor  that 
stimulates  mitochondrial  biogenesis  and  is  a 
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mitochondrial basal transcription machinery [64] (Figure 
2). The indirect regulation of mitochondrial function by 
the  actions  of  the  estrogen  receptor  has  been  reviewed 
elsewhere [65,66].
There is evidence that estrogen acts directly in mito­
chondria by two pathways: one utilizing the receptor and 
the other independent of it [27,67,68]. The presence of 
the estrogen receptor in mitochondria is well established; 
both isoforms, ERα and ERβ, localize to mitochondria in 
diverse cell lines and tissues, yet their functions remain 
contentious. EMSAs suggest that ERβ may bind directly 
to the D­loop of the mitochondrial genome in MCF­7 
breast cancer cells (Figure 1). This binding was stimulated 
by treatment of the cells with estrogen and inhibited by 
treatment with ERβ­specific antibodies [69]. It has not, 
however, been shown that isolated mitochondria respond 
to estrogen treatment by altering gene expression in an 
ERβ­dependent fashion.
Other putative functions for the mitochondrial estro­
gen  receptor  have  focused  on  protein­protein  inter­
actions  identified  using  a  bacterial  two­hybrid  screen. 
This  screen  revealed  that  ERα  can  interact  stably  and 
reproducibly  with  the  mitochondrial  protein  17β­
hydroxysteroid dehydrogenase type 10, suggesting a role 
for  mitochondrial  ERα  in  regulating  cellular  steroid 
metabolism and response [70].
Since cancer is in part a metabolic disease [71], and 
altered mitochondrial DNA sequence and transcription 
levels have been observed in both primary tumors and in 
cancer  cell  lines  [72,73],  a  mitochondrial  role  for  the 
estrogen  receptor  would  be  relevant  to  both  estrogen 
receptor  biology  and  the  study  of  hormone­sensitive 
breast cancer. As with other nuclear factors, however, the 
indirect action of the estrogen receptor on mitochondrial 
gene expression is a confounding factor that complicates 
investigation.  Furthermore,  as  noted  above,  estrogen 
seems  to  regulate  mitochondria  directly,  even  in  the 
absence of its receptor [68]. The disagreement over the 
role  of  mitochondrial  estrogen  receptors  could  be,  in 
part, due to cell­specific functions. Nevertheless, mito­
chondria  are  clearly  an  important  target  of  estrogen 
hormone action.
Other transcription factors
Although only a small number of nuclear transcription 
factors have had a mitochondrial role validated, either in 
a  nucleus­free  in  organello  system  or  by  detection  of 
binding to the mitochondrial genome, there are a number 
of nuclear transcription factors that have been localized 
to  mitochondria  but  where  the  mitochondrial  role 
remains understudied. The glucocorticoid receptor [74], 
the heterodimeric transcription factor AP­1 [75], and the 
peroxisome  proliferator­activated  receptor  γ  (PPARγ) 
[76] have all been detected in mammalian mitochondria, 
and  there  is  some  evidence  for  the  glucocorticoid 
receptor [77] and AP­1 [78] binding to the mitochondrial 
genome to potentially regulate gene expression.
Future directions
The  five  nuclear  transcription  factors  that  have  been 
shown  to  have  distinct  mitochondrial  roles  are  all 
involved in signaling pathways: the estrogen receptor and 
p43  are  nuclear  hormone  receptors  activated  by  a 
hormone  ligand;  CREB  is  phosphorylated  in  a  cyclic­
AMP­dependent manner; Stat3 is stimulated by growth 
hormone signaling pathways; and transcription of p53 is 
activated in response to cell stress. The same signals and 
signaling pathways regulate the mitochondrial pools of 
these proteins, so the mitochondrial and the nuclear roles 
appear to be coordinated regulatory responses. Because 
these  proteins  are  from  different  families  and  the 
characterized  mitochondrial  functions  are  varied,  it 
seems that the development of a mitochondrial role for a 
nuclear  transcription  factor  is  likely  to  be  a  common 
evolutionary strategy for coordinating the two genomes.
The mitochondrial genome and proteome are not only 
regulated  indirectly  via  processes  within  the  nucleus; 
they  are  independently  responsive  to  the  needs  of  the 
cell. The nuclear transcription factors present in mito­
chondria  are  involved  in  oxidative  phosphorylation, 
cellular  metabolism  and  apoptosis,  and  their 
mitochondrion­specific  roles  are  a  key  part  of  their 
biology. The mitochondrial roles of nuclear transcription 
factors  are  likely  to  form  a  core  part  of  their  cellular 
functions, and yet have been explored in detail in only a 
handful of cases. The application of new genomics and 
proteomics  techniques  may  substantially  revise  our 
understanding  of  the  regulatory  interactions  that  exist 
between the nuclear and mitochondrial genomes ­ with 
implications  for  transcription  factor  biology, 
mitochondrial  regulation  and  diseases  such  as  cancer, 
diabetes and obesity.
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